Evidence map›Paper›PMID 27740623›Full record

ArticleCell death and differentiation2017

TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein response.

Roi Isaac, Ido Goldstein, Noa Furth, Neta Zilber, Sarina Streim, Sigalit Boura-Halfon, Eytan Elhanany, Varda Rotter, Moshe Oren, Yehiel Zick

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Whole Exome Sequencing Study in a Family with Type 2 Diabetes Mellitus.International journal of general medicine · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Roi IsaacDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Ido GoldsteinDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Noa FurthDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Neta ZilberDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Sarina StreimDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Sigalit Boura-HalfonDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Eytan ElhananyDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Varda RotterDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Moshe OrenDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Yehiel ZickDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Earlier reported small interfering RNA (siRNA) high-throughput screens, identified seven-transmembrane superfamily member 3 (TM7SF3) as a novel inhibitor of pancreatic β-cell death. Here we show that TM7SF3 maintains protein homeostasis and promotes cell survival through attenuation of ER stress. Overexpression of TM7SF3 inhibits caspase 3/7 activation. In contrast, siRNA-mediated silencing of TM7SF3 accelerates ER stress and activation of the unfolded protein response (UPR). This involves inhibitory phosphorylation of eukaryotic translation initiation factor 2α activity and increased expression of activating transcription factor-3 (ATF3), ATF4 and C/EBP homologous protein, followed by induction of apoptosis. This process is observed both in human pancreatic islets and in a number of cell lines. Some of the effects of TM7SF3 silencing are evident both under basal conditions, in otherwise untreated cells, as well as under different stress conditions induced by thapsigargin, tunicamycin or a mixture of pro-inflammatory cytokines (tumor necrosis factor alpha, interleukin-1 beta and interferon gamma). Notably, TM7SF3 is a downstream target of p53: activation of p53 by Nutlin increases TM7SF3 expression in a time-dependent manner, although silencing of p53 abrogates this effect. Furthermore, p53 is found in physical association with the TM7SF3 promoter. Interestingly, silencing of TM7SF3 promotes p53 activity, suggesting the existence of a negative-feedback loop, whereby p53 promotes expression of TM7SF3 that acts to restrict p53 activity. Our findings implicate TM7SF3 as a novel p53-regulated pro-survival homeostatic factor that attenuates the development of cellular stress and the subsequent induction of the UPR.

Indexed as

Activating Transcription Factor 3Activating Transcription Factor 4AnimalsApoptosisCaspase 3Caspase 7CCAAT-Enhancer-Binding ProteinsCell LineeIF-2 KinaseEndoplasmic Reticulum StressHEK293 CellsHep G2 CellsHumansMembrane GlycoproteinsMiceNitric OxideActivating Transcription Factor 3Activating Transcription Factor 4ATF3 protein, humanATF4 protein, humanCaspase 3Caspase 7CCAAT-Enhancer-Binding ProteinseIF-2 KinaseMembrane GlycoproteinsNitric OxideNitric Oxide Synthase Type IIThapsigarginTM7SF3 protein, humanTranscription Factor CHOPTumor Suppressor Protein p53Tunicamycin

Identifiers

PMID27740623
PMCPMC5260493
OpenAlexW2530061585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.